Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30 | -140 | -20 | -230 | -1,360 |
| Depreciation Amortization | 183 | N/A | N/A | N/A | N/A |
| Other Working Capital | 85 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 0 | 60 | 140 | -60 | 180 |
| Operating Cash Flow | $298 | $-80 | $120 | $-290 | $-1,180 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 8 | -420 | -400 | 270 | 1,040 |
| Investing Cash Flow | $-69 | $-420 | $-400 | $270 | $1,040 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 26 | 340 | 610 | 370 | 7 |
| Financing Cash Flow | $26 | $340 | $610 | $370 | $7 |
| Beginning Cash Position | 1,295 | 1,450 | 1,110 | 760 | 890 |
| End Cash Position | 1,550 | 1,290 | 1,450 | 1,110 | 760 |
| Net Cash Flow | $255 | $-160 | $340 | $350 | $-120 |
| Free Cash Flow | |||||
| Operating Cash Flow | 298 | -80 | 120 | -290 | -1,180 |
| Free Cash Flow | 298 | -80 | 120 | -290 | -1,180 |